Alopecia Areata
📧 Sign up to get email alerts when something new happens for Alopecia Areata.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-24Clinical Trial Update: TREg Activation in the Treatment of the PELADE (Alopecia Areata) [Phase 3]
The document notes the completion of a Phase 3 trial evaluating TREg activation for alopecia areata.
-
CLINICAL_TRIALS trial_result · 2026-03-20Clinical Trial Update: Improving Disease Severity [NA]
A Wake Forest University Health Sciences-sponsored clinical trial update reports a completed study aimed at improving disease severity in ps…
-
CLINICAL_TRIALS trial_result · 2026-03-06Clinical Trial Update: Association of TLR7 Gene rs3853839 Polymorphism With Disease Severity in Alopecia Areata: A Case-Control Study
A completed case-control study examines whether the TLR7 rs3853839 polymorphism is associated with disease severity in alopecia areata.
-
CLINICAL_TRIALS trial_result · 2026-03-06Clinical Trial Update: Impact of NR3C1 rs41423247 (BclI) Polymorphism on Disease Severity in Alopecia Areata
A completed clinical trial conducted at Benha University examined whether the NR3C1 rs41423247 (BclI) polymorphism influences disease severi…
-
CLINICAL_TRIALS trial_result · 2026-02-11Clinical Trial Update: In Vitro Effect Study of Interleukin-2 Muteins on Regulatory T Cells of Patients With Different Autoimmune, Allo-immune or Inflammatory Diseases [NA]
A completed clinical trial update reporting an in vitro study of interleukin-2 muteins on regulatory T cells in patients with autoimmune, al…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-02-09Clinical Trial Update: A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of IMG-007 in Adult Alopecia Areata Participants [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating the safety, pharmacokinetics, and efficacy of IMG-007 in adults with alopecia areata has completed and…
-
CLINICAL_TRIALS trial_result · 2026-01-26Clinical Trial Update: DPCP for the Treatment of Alopecia Areata [Phase 3]
Phase 3 trial of Diphenylcyclopropenone (DPCP) for alopecia areata was terminated, with results posted on 2026-01-26.
-
CLINICAL_TRIALS trial_result · 2025-12-11Clinical Trial Update: Tofacitinib for Immune Skin Conditions in Down Syndrome [Phase 2]
A Phase 2 trial evaluating tofacitinib for immune-mediated skin conditions in individuals with Down syndrome has completed, with results pos…
-
CLINICAL_TRIALS trial_result · 2025-11-21Clinical Trial Update: European Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata [Phase 3]
The European extension of the Phase 3 trial evaluating CTP-543 for alopecia areata has completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2025-11-18Clinical Trial Update: Pre-approval Single-patient Expanded Access for Ritlecitinib (PF-06651600)
This clinical trial update reports pre-approval, single-patient expanded access for ritlecitinib (PF-06651600) in a patient with alopecia ar…
-
CLINICAL_TRIALS trial_result · 2025-10-22Clinical Trial Update: Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata [Phase 2, Phase 3]
This document provides an update on an extension study of CTP-543 for alopecia areata. The study spans Phase 2 and Phase 3 and is currently …
-
CLINICAL_TRIALS trial_result · 2025-10-20Clinical Trial Update: HCW9302 (Interleukin-2 Fusion Protein) for Alopecia Areata [Phase 1]
HCW Biologics is recruiting for a Phase 1 trial of HCW9302, an interleukin-2 fusion protein, to treat alopecia areata.
-
CLINICAL_TRIALS trial_result · 2025-10-01Clinical Trial Update: A Study of Baricitinib (LY3009104) in Participants With Severe or Very Severe Alopecia Areata [Phase 2, Phase 3]
Phase 2/3 clinical trial results for baricitinib in participants with severe or very severe alopecia areata have been completed and results …
-
CLINICAL_TRIALS trial_result · 2025-09-30Clinical Trial Update: A Study to Learn About the Medicine Called Ritlecitinib in Adults With Severe Alopecia Areata in Real-world Settings
Pfizer-sponsored real-world study evaluating Ritlecitinib in adults with severe alopecia areata has completed.
-
CLINICAL_TRIALS trial_result · 2025-09-15Clinical Trial Update: Evaluation of the Efficacy and Safety of Oral Roflumilast Versus Intralesional Corticosteroids Injection (ILCs) in the Treatment of Alopecia Areata [Phase 4]
A Phase 4 trial evaluating the efficacy and safety of oral roflumilast compared with intralesional corticosteroid injections for alopecia ar…
-
CLINICAL_TRIALS trial_result · 2025-08-14Clinical Trial Update: Long-Term PF-06651600 for the Treatment of Alopecia Areata [Phase 3]
Pfizer completed a long-term Phase 3 trial of PF-06651600 for alopecia areata. Results have been posted.
-
CLINICAL_TRIALS trial_result · 2025-08-07Clinical Trial Update: Rhofanib® (Tofacitinib) Safety and Effectiveness Evaluation
Completed clinical trial evaluating the safety and effectiveness of Rhofanib (tofacitinib) for alopecia areata and its severe forms, alopeci…
-
CLINICAL_TRIALS trial_result · 2025-07-01Clinical Trial Update: The Impact of Untreated Depression and Anxiety Among Patients With Skin Diseases in Jeddah, Saudi Arabia.
This clinical trial update summarizes the impact of untreated depression and anxiety on patients with skin diseases in Jeddah, Saudi Arabia.…
-
CLINICAL_TRIALS trial_result · 2025-06-18Clinical Trial Update: Healthcare Disparities in Alopecia Areata
A clinical trial update reports completed results on healthcare disparities in alopecia areata. The study, sponsored by Momentum Data, has p…
-
CLINICAL_TRIALS trial_result · 2025-06-08Clinical Trial Update: Development and EValuation of an Online Intervention to Reduce Self-Stigma in People With Visible Chronic Skin disEases [NA]
A completed clinical trial conducted by Universitätsklinikum Hamburg-Eppendorf evaluating an online intervention to reduce self-stigma in pe…
-
CLINICAL_TRIALS trial_result · 2025-04-10Clinical Trial Update: Study of EQ101 in Adult Subjects With Moderate to Severe Alopecia Areata [Phase 2]
A Phase 2 study of EQ101 in adults with moderate-to-severe alopecia areata has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2025-03-18Clinical Trial Update: Extension Study to Evaluate Safety and Efficacy of Jaktinib in Adults With Alopecia Areata [Phase 3]
This update covers the extension Phase 3 trial of Jaktinib in adults with Alopecia Areata, evaluating safety and efficacy. The study status …
-
CLINICAL_TRIALS trial_result · 2025-03-14Clinical Trial Update: Study to Evaluate the Safety and Efficacy of Jaktinib in Adults With Alopecia Areata [Phase 3]
Phase 3 clinical trial update showing the safety and efficacy evaluation of Jaktinib in adults with alopecia areata; the study has completed…
-
CLINICAL_TRIALS trial_result · 2025-02-28Clinical Trial Update: A Study to Evaluate Efficacy and Safety of Deucravacitinib in Participants With Alopecia Areata [Phase 2]
Phase 2 trial evaluating the efficacy and safety of deucravacitinib in participants with alopecia areata was terminated, with results posted…
-
CLINICAL_TRIALS trial_result · 2025-02-24Clinical Trial Update: Efficacy of Twice Daily Application of LEO 124249 Ointment 30 mg/g for 12 Weeks on Eyebrow Alopecia Areata. [Phase 2]
Clinical trial update on the efficacy of twice-daily LEO 124249 ointment 30 mg/g for eyebrow alopecia areata in a Phase 2 study that was ter…